RUNX1 and cancer: Recent studies have suggested that RUNX1 and Foxp3 can synergistically inhibit cancer cell proliferation and apoptosis, suppressing the growth and spread of cancer cells by inhibiting metabolic pathways and Ras or other signaling pathways.